Evidence map›Paper›PMID 30974725›Full record

ArticleMolecules (Basel, Switzerland)2019

Introduction to the Molecules Special Edition Entitled '

Edwin A Yates, John T Gallagher, Marco Guerrini

Open access · goldAbstract readEditorial
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Edwin A YatesDepartment of Biochemistry, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK. eayates@liv.ac.uk.
John T GallagherUniversity of Manchester and Iduron Ltd, Biohub, Alderley Park, Alderley Edge, Cheshire SK10 4TG, UK. john@iduron.co.uk.
Marco GuerriniRonzoni Institute for Chemical and Biochemical research, Via G Colombo 81, Milano 20133, Italy. guerrini@ronzoni.it.
Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni · ITUniversity of Liverpool · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scope of this article is to provide a brief general introduction to heparan sulfate (HS) and heparin, and attempt to identify some of the central challenges regarding research into the chemistry and biology of glycosaminoglycans (GAGs), some of which are the subject of contributions to the special issue of

Indexed as

Biomedical ResearchHeparan SulfateHeparinPeriodicals as TopicHeparan SulfateHeparin

Identifiers

PMID30974725
PMCPMC6479682
OpenAlexW2936000691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.